![Peter Radovich](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Peter Radovich
President at
MIRUM PHARMACEUTICALS, INC.
Net worth: 5 M $ as of 2026-09-29
Profile
Mr. Peter Radovich is an Independent Director at MBX Biosciences, Inc. and a President & Chief Operating Officer at Mirum Pharmaceuticals, Inc. He is on the Board of Directors at MBX Biosciences, Inc. Mr. Radovich was previously employed as an Independent Director by Rain Oncology, Inc., a Senior Vice President-Operations by Global Blood Therapeutics, Inc., a Vice President-Global Product Kyprolis by Onyx Pharmaceuticals, Inc., a Principal by Chiron Corp., and a Senior Director & VP-Program Leadership by Onyx Pharmaceuticals, Inc. He received his undergraduate degree from Texas Christian University and an MBA from the University of Washington.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2026-06-04 | 57,260 ( 0.09% ) | 5 M $ | 2026-09-29 |
Peter Radovich active positions
| Companies | Position | Start |
|---|---|---|
| MIRUM PHARMACEUTICALS, INC. | President | 2024-01-15 |
| MBX BIOSCIENCES, INC. | Director/Board Member | 2026-10-19 |
Former positions of Peter Radovich
| Companies | Position | End |
|---|---|---|
| RAIN ONCOLOGY INC. | Director/Board Member | 2024-01-24 |
| GLOBAL BLOOD THERAPEUTICS, INC. | Chief Operating Officer | 2020-03-31 |
Onyx Pharmaceuticals, Inc.
 Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Corporate Officer/Principal | 2013-12-31 |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Director/Board Member | 2006-08-31 |
Chiron Corp.
 Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Corporate Officer/Principal | 2005-12-31 |
Education of Peter Radovich
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
67
1st degree connections
8
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 8 |
|---|---|
Chiron Corp.
Chiron Corp. Medical SpecialtiesHealth Technology Provides nucleic acid test for blood screening | Health Technology |
Onyx Pharmaceuticals, Inc.
Onyx Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that provide therapeutics for cancer | Health Technology |
University of Washington
 University of Washington Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Texas Christian University
 Texas Christian University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Global Blood Therapeutics, Inc.
 Global Blood Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which provides treatment and care of sickle cell disease for inherited blood disorder | Health Technology |
Rain Oncology, Inc.
 Rain Oncology, Inc. BiotechnologyHealth Technology Operates as a clinical-stage precision oncology company that develops therapeutics for cancer patients | Health Technology |
Mirum Pharmaceuticals, Inc.
 Mirum Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as clinical-stage therapeutics company developing a novel approach for treating cholestasis liver diseases | Health Technology |
MBX Biosciences, Inc.
 MBX Biosciences, Inc. BiotechnologyHealth Technology Operates as a clinical-stage biopharmaceutical company focused on discovery and development of novel precision peptide therapies for endocrine & metabolic disorders | Health Technology |
- Stock Market
- Insiders
- Peter Radovich
